» Authors » T J Polascik

T J Polascik

Explore the profile of T J Polascik including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 49
Citations 929
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
van Luijtelaar A, Greenwood B, Ahmed H, Barqawi A, Barret E, Bomers J, et al.
World J Urol . 2019 Jan; 37(10):2147-2153. PMID: 30671638
Purpose: To define the role of focal laser ablation (FLA) as clinical treatment of prostate cancer (PCa) using the Delphi consensus method. Methods: A panel of international experts in the...
2.
Tay K, Gupta R, Holtz J, Silverman R, Tsivian E, Schulman A, et al.
Prostate Cancer Prostatic Dis . 2017 Apr; 20(3):323-327. PMID: 28440322
Background: Active surveillance (AS) has excellent short to medium term outcomes in well-selected prostate cancer patients. Traditional biopsy-based selection criteria have been criticized for inaccurate determination of cancer grade and...
3.
Tay K, Scheltema M, Ahmed H, Barret E, Coleman J, Dominguez-Escrig J, et al.
Prostate Cancer Prostatic Dis . 2017 Mar; 20(3):294-299. PMID: 28349978
Background: Whole-gland extirpation or irradiation is considered the gold standard for curative oncological treatment for localized prostate cancer, but is often associated with sexual and urinary impairment that adversely affects...
4.
Scheltema M, Tay K, Postema A, de Bruin D, Feller J, Futterer J, et al.
World J Urol . 2016 Sep; 35(5):695-701. PMID: 27637908
Purpose: To codify the use of multiparametric magnetic resonance imaging (mpMRI) for the interrogation of prostate neoplasia (PCa) in clinical practice and focal therapy (FT). Methods: An international collaborative consensus...
5.
Tay K, Polascik T
Arch Esp Urol . 2016 Jul; 69(6):317-26. PMID: 27416635
Objective: To systematically review the oncological and functional outcomes of contemporary primary prostate focal cryotherapy for localized prostate cancer in the context of current developments in prostate focal therapy. Methods:...
6.
Postema A, de Reijke T, Ukimura O, van den Bos W, Azzouzi A, Barret E, et al.
World J Urol . 2016 Feb; 34(10):1373-82. PMID: 26892160
Purpose: To reach standardized terminology in focal therapy (FT) for prostate cancer (PCa). Methods: A four-stage modified Delphi consensus project was undertaken among a panel of international experts in the...
7.
Baust J, Bischof J, Jiang-Hughes S, Polascik T, Rukstalis D, Gage A, et al.
Prostate Cancer Prostatic Dis . 2015 Jan; 18(2):87-95. PMID: 25622539
It is now recognized that the tumor microenvironment creates a protective neo-tissue that isolates the tumor from the various defense strategies of the body. Evidence demonstrates that, with successive therapeutic...
8.
Muller B, van den Bos W, Brausi M, Futterer J, Ghai S, Pinto P, et al.
World J Urol . 2015 Jan; 33(10):1503-9. PMID: 25559111
Introduction: Focal therapy can offer the middle ground for treatment between active surveillance and radical therapy in patients with low- and intermediate-risk prostate cancer. Factors that prohibit focal therapy from...
9.
Azrad M, Vollmer R, Madden J, Polascik T, Snyder D, Ruffin 4th M, et al.
Biotech Histochem . 2014 Dec; 90(3):184-9. PMID: 25434394
In vitro bioassay has been used extensively to test the effects of culturing cancer cells in sera from humans participating in dietary interventions, i.e, studies of modified intake of nutrients...
10.
Kimura M, Banez L, Polascik T, Bernal R, Gerber L, Robertson C, et al.
Andrology . 2013 Feb; 1(2):256-61. PMID: 23413138
Changes in sexual bother (SB) following radical prostatectomy (RP) negatively affect health-related quality of life (HRQoL) of prostate cancer survivors. However, post-operative SB tends to be neglected whereas sexual function...